Trials / Conditions / High-risk NMIBC
High-risk NMIBC
4 registered clinical trials studyying High-risk NMIBC — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC NCT07322263 | Michael A. O'Donnell | Phase 2 |
| Not Yet Recruiting | Observational Clinical Study on High - Risk NMIBC Patients Choosing Trimodality Bladder - Sparing Therapy NCT07053748 | Peking University First Hospital | — |
| Active Not Recruiting | A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer NCT06181266 | Prokarium Ltd | Phase 1 |
| Recruiting | A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC NCT05410730 | Shanghai Hengrui Pharmaceutical Co., Ltd. | Phase 1 / Phase 2 |